1. Home
  2. GSM vs KURA Comparison

GSM vs KURA Comparison

Compare GSM & KURA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Ferroglobe PLC

GSM

Ferroglobe PLC

HOLD

Current Price

$3.29

Market Cap

730.6M

ML Signal

HOLD

Logo Kura Oncology Inc.

KURA

Kura Oncology Inc.

HOLD

Current Price

$10.78

Market Cap

841.6M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
GSM
KURA
Founded
2015
2014
Country
United Kingdom
United States
Employees
N/A
N/A
Industry
Metal Mining
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Basic Materials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
730.6M
841.6M
IPO Year
2015
2015

Fundamental Metrics

Financial Performance
Metric
GSM
KURA
Price
$3.29
$10.78
Analyst Decision
Strong Buy
Buy
Analyst Count
1
11
Target Price
$6.00
$25.56
AVG Volume (30 Days)
1.5M
1.8M
Earning Date
05-05-2026
05-12-2026
Dividend Yield
1.34%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$67,482,000.00
Revenue This Year
$23.36
$28.28
Revenue Next Year
$17.85
$106.37
P/E Ratio
N/A
N/A
Revenue Growth
N/A
25.24
52 Week Low
$3.10
$5.45
52 Week High
$5.74
$12.49

Technical Indicators

Market Signals
Indicator
GSM
KURA
Relative Strength Index (RSI) 32.69 63.42
Support Level N/A $8.72
Resistance Level $4.68 $11.29
Average True Range (ATR) 0.19 0.48
MACD -0.06 0.15
Stochastic Oscillator 16.27 84.57

Price Performance

Historical Comparison
GSM
KURA

About GSM Ferroglobe PLC

Ferroglobe PLC provides silicon-based alloys and specialty metals. It produces silicon metal and silicon and manganese-based alloy, serving customers in the specialty chemical, aluminum, solar, steel, and ductile iron foundry industries. The company's operating segments include Canada - Silicon Metals, Canada - Silicon Alloys, U.S. - Silicon Metals, U.S. - Silicon Alloys, Europe - Manganese Alloys, Europe - Silicon Metals, Europe - Silicon Alloys, South Africa - Silicon Metals, South Africa - Silicon Alloys, and Other segments. The primary raw materials the company uses to produce its electrometallurgy products include its coal and quartz mining operations and its silicon metal and ferroalloy production. The firm generates key revenue from Silicon metal and Manganese-based alloys.

About KURA Kura Oncology Inc.

Kura Oncology Inc is a biopharmaceutical company focused on the discovery, development, and commercialization of targeted therapies for the treatment of cancer. The company develops small-molecule medicines designed to target cancer signaling pathways in oncology and hematology. Its pipeline includes menin inhibitor ziftomenib for the treatment of acute myeloid leukemia and other hematologic malignancies, as well as additional product candidates such as KO-7246 and darolifarnib being evaluated for solid tumors and other diseases.

Share on Social Networks: